Video: Lani Alison on How Innovation Is Being Used to Improve Quality Metrics in Oncology
(8/6, The American Journal of Managed Care) “Innovation is being used to improve quality metrics in oncology care when it comes to the patient and in data, explained Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates.” View Video
Core Outcome Sets – What are They?
(8/5, Aimee Lee Russell, National Health Council Blog) comments “...In core outcome set development, stakeholders come together to identify which outcomes are the most important and should be measured consistently across all studies in a given disease. Of course, researchers are welcome to also measure outcomes beyond those included in a core set, but at a minimum, they should measure the outcomes within the agreed upon core set. It's essential that patients participate in core outcome set development to ensure that outcomes included in the core set reflect the things that patients care about.” Full
Discrimination Has No Place in American Prescription Drug Coverage
(8/6, Sue Peschin, The Tennessean) comments “...Health coverage is a necessity, not an optional commodity like a box of cereal. There is no question that we need to address total costs of health care and the specific impact of prescription drug costs on public and private payers as well as patients and their families. However, unless we decide as a nation that we want to start rationing health care overall, let alone doing it based on age or disability, ICER is a nonstarter.” Full
'Spin' Found in over Half of Clinical Trial Abstracts Published in Top Psychiatry Journals
(8/5, BMJ Press Release) “'Spin'--exaggerating the clinical significance of a particular treatment without the statistics to back it up--is apparent in more than half of clinical trial abstracts published in top psychology and psychiatry journals, finds a review of relevant research in BMJ Evidence Based Medicine. The findings raise concerns about the potential impact this might be having on treatment decisions, as the evidence to date suggests that abstract information alone is capable of changing doctors' minds, warn the study authors.” Full
Initial Results of Real-World Evidence Pilot Study Published in JCO Clinical Cancer Informatics
(8/6, COTA, Inc. Press Release) “...The initial paper, ‘An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer,’ was authored by COTA, Friends of Cancer Research and other experts across the industry and was recently published in JCO Clinical Cancer Informatics. The pilot study explores how well findings from six RWE data sources match the findings of randomized clinical trials for advanced non-small cell lung cancer.” Full
Assessing Low-Value Health Care Services In The Military Health System
Tracey Pérez Koehlmoos, et al.
August 2019, Health Affairs
Evaluation of Spin in Abstracts of Papers in Psychiatry and Psychology Journals
Samuel Jellison, et al.
August 5, 2019, BMJ Evidence-Based Medicine
BMJ Evidence-Based Medicine
Building Evidence and Measuring Clinical Outcomes for Genomic Medicine
Josh F Peterson, MD, et al.
August 5, 2019, The Lancet
The Importance of Measuring the Impact of Patient-Oriented Research
Diane Aubin, Marilynne Hebert and Dean Eurich
August 6, 2019, CMAJ